Format

Send to

Choose Destination
J Alzheimers Dis. 2011;24 Suppl 2:111-26. doi: 10.3233/JAD-2011-110164.

Oxidative stress treatment for clinical trials in neurodegenerative diseases.

Author information

1
Department of Neuroscience, Clinical Neurology, University of Pisa, Pisa, Italy.

Abstract

Oxidative stress is a metabolic condition arising from imbalance between the production of potentially reactive oxygen species and the scavenging activities. Mitochondria are the main providers but also the main scavengers of cell oxidative stress. The role of mitochondrial dysfunction and oxidative stress in the pathogenesis of neurodegenerative diseases is well documented. Therefore, therapeutic approaches targeting mitochondrial dysfunction and oxidative damage hold great promise in neurodegenerative diseases. Despite this evidence, human experience with antioxidant neuroprotectants has generally been negative with regards to the clinical progress of disease, with unclear results in biochemical assays. Here we review the antioxidant approaches performed so far in neurodegenerative diseases and the future challenges in modern medicine.

PMID:
21422516
DOI:
10.3233/JAD-2011-110164
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for IOS Press
Loading ...
Support Center